Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	23.32	31.98	25.93
Graham Fair Price	20.76	24.29	20.11
PEG	-36.94	0.30	-0.47
Price/Book	-16.03	4.37	5.21
Price/Cash Flow	-18.02	34.74	42.38
Prices/Earnings	-23.24	7.88	10.27
Price/Sales	-6.89	11.17	12.00
Price/FCF	-18.02	34.74	42.38
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.80	0.68	0.65
Operating Margin	-30.14	0.27	0.39
ROA	14.31	0.07	0.06
ROE	0.13	0.14	9.40
ROIC	0.07	0.05	-28.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.09	< 0.005	4190.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.22	-0.27	20.69
EPS QOQ	-0.22	0.26	21.73
FCF QOQ	-0.02	0.19	905.39
Revenue QOQ	0.11	0.05	-57.60
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	46.42	53.12	14.42
Days Sales Outstanding (DSO)	72.28	82.07	13.55
Inventory Turnover	1.94	1.69	-12.60
Debt/Capitalization	0.43	0.37	-13.30
Quick Ratio	5.33	4.45	-16.45
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.91	13.75	15.46
Cash	10.42	10.45	0.27
Capex	-0.18	-0.12	31.71
Free Cash Flow	1.46	1.73	18.26
Revenue	5.17	5.38	4.12
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.80	4.84	-16.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.60	-1.25	-106.31
Naive Interpretation	Member

06 - Financial Health · Bad

Rating